| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_87343f0391f5074a8ffb73f681e41648
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_384ef07b62eaaaa2ef5fbb9822b915c0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2b2f4d1e7d3a550218d34bb207b722dd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_828b5639fe27c2b6ac07ac2bd5da63ec
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_37f4922dfb7777b019e504b885211b8e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9eb081a04414bbd0e968cdd8145e874d |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-4739 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57419
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-574 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
| filingDate |
2011-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_72e2d63d9036968c9522077d938a3816
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dc1598c4b80e41f76c532d221187c3a0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_264cc3f1223f23c69356048db3800954
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2858b212f3c4d54144fb528febf3b8a1 |
| publicationDate |
2012-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2012052629-A2 |
| titleOfInvention |
Tumourigenesis biomarkers and uses for obtaining anti-metastatic compounds |
| abstract |
The invention relates to Cyc A2 for use as a specific biomarker of the invasive capacity of cancer cells of human or animal origin and to a method for evaluating the invasive power of cancer cells. Use as medicaments and for the screening of anti-metastatic compounds. |
| priorityDate |
2010-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |